Advanced search
Publication Cover
Cancer Biology & Therapy Volume 14, 2013 - Issue 2
Submit an article Journal homepage
869
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration

Caterina Ierano Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA; Oncological Immunology; National Cancer Institute of Naples; “G. Pascale Foundation”; Naples, Italy
,
Agnes Basseville Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA
,
Kenneth K.W. To Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA
,
Zhirong Zhan Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA
,
Robert W. Robey Medical Oncology Branch; National Cancer Institute; Bethesda, MD USACorrespondence[email protected]
,
Julia Wilkerson Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA
,
Susan E. Bates Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA
&
Stefania Scala Oncological Immunology; National Cancer Institute of Naples; “G. Pascale Foundation”; Naples, Italy
 show all
Pages 175-183 | Received 26 Oct 2012, Accepted 18 Nov 2012, Published online: 28 Nov 2012

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Enrique Pérez-Cárdenas, Lucía Taja-Chayeb, Catalina Trejo-Becerril, José Chanona-Vilchis, Alma Chávez-Blanco, Guadalupe Domínguez-Gómez, Elizabeth Langley, Alejandro García-Carrancá & Alfonso Dueñas-González. (2018) Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells. OncoTargets and Therapy 11, pages 8823-8833.
Read now
Paul Dent. (2013) HDACIs and the inhibition of invasive potential. Cancer Biology & Therapy 14:9, pages 776-777.
Read now

Articles from other publishers (11)

Başak Aru, Aysel Günay, Gülderen Yanıkkaya Demirel, Ayşe Gül Gürek & Devrim Atilla. (2021) Evaluation of histone deacetylase inhibitor substituted zinc and indium phthalocyanines for chemo- and photodynamic therapy. RSC Advances 11:55, pages 34963-34978.
Crossref
Muhammad Jahangeer, Areej Riasat, Zahed Mahmood, Muhammad Numan, Naveed Munir, Mehvish Ashiq, Muhammad Asad, Usman Ali & Mahwish Salman. 2021. Saccharomyces. Saccharomyces.
Eiman Najjar, Elsebeth Staun-Ram, Anat Volkowich & Ariel Miller. (2020) Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS. Journal of Neuroimmunology 343, pages 577230.
Crossref
Ruchi Saxena, Yan Wang & James W. Mier. (2020) CXCR4 inhibition modulates the tumor microenvironment and retards the growth of B16-OVA melanoma and Renca tumors. Melanoma Research 30:1, pages 14-25.
Crossref
Kaibo Guo, Guan Feng, Qingying Yan, Leitao Sun, Kai Zhang, Fengfei Shen, Minhe Shen & Shanming Ruan. (2019) CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members. Molecular Medicine Reports.
Crossref
Rosie M. Butler, Robert C. McKenzie, Christine L. Jones, Charlotte E. Flanagan, Wesley J. Woollard, Maria Demontis, Silvia Ferreira, Isabella Tosi, Susan John, Sean J. Whittaker & Tracey J. Mitchell. (2019) Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance. Journal of Investigative Dermatology 139:9, pages 1975-1984.e2.
Crossref
Sara Santagata, Maria Napolitano, Crescenzo D'Alterio, Sonia Desicato, Salvatore Di Maro, Luciana Marinelli, Alessandra Fragale, Maria Buoncervello, Francesco Persico, Lucia Gabriele, Ettore Novellino, Nicola Longo, Sandro Pignata, Sisto Perdonà & Stefania Scala. (2017) Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer. Oncotarget 8:44, pages 77110-77120.
Crossref
Sanjeev Banerjee & Shivani B. Paruthy. 2017. Fungal Metabolites. Fungal Metabolites 669 700 .
Sanjeev Banerjee & Shivani B. Paruthy. 2016. Fungal Metabolites. Fungal Metabolites 1 32 .
Stefania Scala. (2015) Molecular Pathways: Targeting the CXCR4–CXCL12 Axis—Untapped Potential in the Tumor Microenvironment. Clinical Cancer Research 21:19, pages 4278-4285.
Crossref
Swathi Ramakrishnan & Roberto Pili. (2013) Histone Deacetylase Inhibitors and Epigenetic Modifications as a Novel Strategy in Renal Cell Carcinoma. The Cancer Journal 19:4, pages 333-340.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.